AGA Medical to Webcast Third-Quarter Earnings Conference Call Tuesday, Nov. 3

Live Webcast at 4 p.m. CT

• Press Release
• Source: AGA Medical Holdings, Inc.
• On 9:00 am EDT, Wednesday October 28, 2009

MINNEAPOLIS--(BUSINESS WIRE)--AGA Medical Holdings, Inc. (AGA Medical) (NASDAQ: AGAM - News) will host a live webcast of its third-quarter conference call on Tuesday, Nov. 3, 2009, at 4 p.m. CT. AGA Medical President and Chief Executive Officer John Barr and Chief Financial Officer Brigid Makes will discuss the company’s results for the third quarter ended Sept. 30, 2009. The company will issue an earnings release after market close on Tuesday, Nov. 3, 2009.

Related Quotes

Symbol	Price	Change
AGAM	12.33	-0.05

{"s" : "agam","k" : "c10,l10,p20,t10","o" : "","j" : ""}

To access the live webcast, go to the investor information section of the company’s Web site, www.amplatzer.com, on the day of the conference call and click on the webcast icon. A webcast replay will be available beginning at 6:30 p.m. CT that day.

To participate in the conference call, dial (888) 680-0894 and enter 16851461. Please dial in at least 10 minutes prior to the call. Participants may pre-register online for the call by logging on to the following Web site: https://www.theconferencingservice.com/prereg/key.process?key=PXK9E3HPX.

If you do not have access to the Internet and want to listen to an audio replay of the conference call, dial (888) 286-8010 and enter access number 87407374. The audio replay will be available beginning at 6:30 p.m. CT on Tuesday, Nov. 3, 2009, through 6:30 p.m. CT on Tuesday, Nov. 17, 2009.

About AGA Medical

AGA Medical, based in Plymouth, Minn., is a leader in developing interventional devices for the minimally invasive treatment of structural heart defects and peripheral vascular disorders. Founded in 1995 by Dr. Kurt Amplatz, a former University of Minnesota professor and researcher, AGA Medical’s range of AMPLATZER® products help improve patient outcomes, reduce length of hospital stay and accelerate patient recovery times. AMPLATZER products significantly advanced the treatment of the most common congenital “holes in the heart,” such as atrial septal defects, patent foramen ovale and ventricular septal defects. More than 1,500 articles supporting the benefits of AMPLATZER products have been published in medical literature. AGA Medical markets AMPLATZER products in 101 countries worldwide. For more information, visit www.amplatzer.com.

For AGA Medical:
Padilla Speer Beardsley
Nick Banovetz, 612-455-1705
nbanovetz@psbpr.com